Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Perspective Therapeutics Inc CATX

Healthcare Biotechnology
Perspective Therapeutics, Inc. is a radiopharmaceutical development company that is developing advanced treatment applications for cancers throughout the body. The Company has proprietary technology that utilizes the alpha-emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides. It is also developing imaging diagnostics that... see more

Recent & Breaking News (NYSEAM:CATX)

Isoray Announces Record Third Quarter Fiscal 2019 Financial Results

GlobeNewswire May 9, 2019

Isoray To Announce Third Quarter Fiscal 2019 Financial Results on May 9, 2019

GlobeNewswire May 1, 2019

Thinking about buying stock in Bank of America, Dr. Pepper Snapple Group, Groupon, Isoray or Snap Inc.?

PR Newswire July 10, 2018

IsoRay to Present at the 8th Annual LD Micro Invitational

Accesswire May 31, 2018

IsoRay to Present at the Planet MicroCap Showcase 2018 on April 25 in Las Vegas, NV

Accesswire April 19, 2018

IsoRay, Inc. to Host Earnings Call

Accesswire February 8, 2018

IsoRay to Present at the 10th Annual LD Micro Main Event

Accesswire November 28, 2017

IsoRay, Inc. to Host Earnings Call

Accesswire November 14, 2017

IsoRay Announces First Quarter Fiscal 2018 Earnings Conference Call

Marketwired November 8, 2017

IsoRay Announces Fourth Quarter Fiscal 2017 Revenue of $1.37 Million, 22% Fourth Quarter-over-Fourth Quarter Increase

PR Newswire September 28, 2017

IsoRay Announces Study Accepted for Publication in the International Journal of Radiation Oncology, Biology, Physics entitled "Re-irradiation using Permanent Interstitial Brachytherapy (PIB): A Potentially Durable Technique for Salvaging Recurrent Pelvic

PR Newswire September 26, 2017

IsoRay Announces "Long-term PSA Outcomes in a Single Institution, Prospective Randomized Cesium-131 / Iodine-125 Permanent Prostate Brachytherapy Trial" Poster Presentation at 2017 Annual American Society for Radiation Oncology (ASTRO) Conference

PR Newswire September 25, 2017

IsoRay Announces Participation At The 19th Annual Rodman & Renshaw Global Investment Conference In New York City September 10-12, 2017

PR Newswire August 31, 2017

IsoRay Announces Preliminary Fourth Quarter F2017 Revenue of $1.37 Million, 22% Year-over-Year Increase

PR Newswire August 4, 2017

New Study Shows Brachytherapy And Cesium-131 Isotope Treatment Beneficial For Prostate Cancer Patients

PR Newswire August 1, 2017

IsoRay Announces Appointment of Mark Austin as Controller, Principal Accounting and Financial Officer

PR Newswire July 7, 2017

IsoRay Receives FDA Response to 510(k) Application for GammaTile™

PR Newswire July 6, 2017

IsoRay Announces Study Published in The International Journal of Radiation Oncology, Biology, Physics entitled, "Clinical Outcomes of Large Brain Metastases Treated with Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Pro

PR Newswire June 20, 2017

IsoRay Announces Third Quarter Fiscal 2017 Financial Results

PR Newswire May 10, 2017

IsoRay Announces Study Accepted for Publication in The International Journal of Radiation Oncology, Biology, Physics entitled "Long-term Quality of Life in Prostate Cancer Patients Treated with Cesium-131"

PR Newswire May 3, 2017